Neurocrine Bioscienc (NBIX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2014 | 06-2014 | 03-2014 | 12-2013 | 09-2013 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 29,046 | 37,445 | 105,532 | 44,789 | 34,889 |
| Marketable Securities | 150,628 | 157,211 | 114,330 | 100,950 | 122,022 |
| Receivables | N/A | 2,919 | 1,873 | N/A | 75 |
| Other current assets | 4,194 | 0 | 0 | 2,723 | 2,232 |
| TOTAL | $183,868 | $197,575 | $221,735 | $148,462 | $159,218 |
| Non-Current Assets | |||||
| PPE Net | 2,292 | 2,239 | 1,798 | 1,771 | 1,739 |
| Investments And Advances | 67,148 | 65,282 | 51,320 | 0 | 675 |
| Other Non-Current Assets | 4,443 | 4,443 | 4,443 | 4,443 | 4,335 |
| TOTAL | $73,883 | $71,964 | $57,561 | $6,214 | $6,749 |
| Total Assets | $257,751 | $269,539 | $279,296 | $154,676 | $165,967 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 900 | 846 | 818 | 101 | 1,097 |
| Accrued Expenses | 9,307 | 7,439 | 6,111 | 7,955 | 7,882 |
| TOTAL | $14,045 | $12,053 | $10,608 | $11,699 | $13,321 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 3,384 | 3,327 | 3,251 | 3,227 | 3,933 |
| Other Non-Current Liabilities | 2,176 | 2,202 | 2,248 | 2,242 | 2,107 |
| TOTAL | $19,669 | $20,641 | $21,631 | $22,567 | $23,354 |
| Total Liabilities | $33,714 | $32,694 | $32,239 | $34,266 | $36,675 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 76,005 | 75,919 | 75,863 | 67,794 | 67,343 |
| Common Shares | 76 | 76 | 76 | 67 | 67 |
| Retained earnings | -806,861 | -790,986 | -777,605 | -765,763 | -755,121 |
| Other shareholders' equity | -207 | -126 | -194 | 5 | -9 |
| TOTAL | $224,037 | $236,845 | $247,057 | $120,410 | $129,292 |
| Total Liabilities And Equity | $257,751 | $269,539 | $279,296 | $154,676 | $165,967 |